Cogstate Limited (COGZF)

Market Cap	320.47M +71.8%
Revenue (ttm)	56.07M +18.8%
Net Income	10.78M +46.7%
EPS	0.06 +44.6%
Shares Out	n/a
PE Ratio	29.74
Forward PE	22.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	849
Open	1.600
Previous Close	1.600
Day's Range	1.600 - 1.880
52-Week Range	1.000 - 2.100
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: OTCMKTS
• Ticker Symbol: COGZF

Financial Performance

In fiscal year 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error